REQUEST A DEMO
Total
USD $0.00
Search more companies

Niarmedik Plus OOO (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Niarmedik Plus OOO Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

"Niarmedik Plus" is a Russian medical, pharmaceutical and biotechnological company focusing on the following main business lines: development, manufacture and sales (including distribution) of diagnostic kits and reagents for viral and other infectious diseases; sales of medical laboratory equipment; development and production of original pharmaceutical products; provision of medical and clinical laboratory services. Production of drugs; immunodiagnostic test kits for diagnosis of infection; delivery of diagnostic equipment for bacteriological, virological clinical laboratories. Medical diagnostic, counseling and treatment centre. Training for laboratory diagnosis.

Headquarters
Kozhevnicheskaya, 14, 5, 3
Moscow; Moscow; Postal Code: 115114

Contact Details: Purchase the Niarmedik Plus OOO report to view the information.

Website: http://kalugascreen.ru

Basic Information
Total Employees:
Purchase the Niarmedik Plus OOO report to view the information.
Outstanding Shares:
Purchase the Niarmedik Plus OOO report to view the information.
Registered Capital:
Purchase the Niarmedik Plus OOO report to view the information.
Incorporation Date:
June 23, 2023
Key Executives
Purchase this report to view the information.
Management Company
Ownership Details
Purchase this report to view the information.
99.999%
Subsidiaries
Biofarmaholding OOO
99%
Matrifleks OOO
75%
Dts OOO
70%
Company Performance
Financial values in the chart are available after Niarmedik Plus OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-19.72%
Total operating revenue
-19.72%
Operating profit (EBIT)
38.72%
Net Profit (Loss) for the Period
-645.98%
Total assets
-95.53%
Total equity
-99.4%
Operating Profit Margin (ROS)
18.16%
Net Profit Margin
-1464.48%
Return on Equity (ROE)
-10390.74%
Quick Ratio
-0.51%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?